Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

43.8K
Overview
43.8K
Diphtheria01:28

Diphtheria

169
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
169
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

70
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
70
Vaccines01:21

Vaccines

86
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
86
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

1.1K
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
1.1K
Cholera01:25

Cholera

140
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
140

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Grassroots Indicators for Pandemic Prevention, Preparedness, and Response: A Systematic Narrative Review.

International journal of health policy and management·2026
Same author

The Lancet Commission on improving population health post-COVID-19.

Lancet (London, England)·2025
Same author

The Lancet One Health Commission: harnessing our interconnectedness for equitable, sustainable, and healthy socioecological systems.

Lancet (London, England)·2025
Same author

Including louse-borne <i>Bartonella quintana</i> as a nationally notifiable disease: a step towards health equity.

Lancet regional health. Americas·2025
Same author

Pandemic financing should learn from revolving funds.

Lancet (London, England)·2024
Same author

Universal health care, healthier populations, and stronger public health: how SEARO is working with countries to strengthen disease control and preparedness through its flagship priorities.

The Lancet regional health. Southeast Asia·2023
Same journal

Descending Necrotizing Mediastinitis Across Age and Host-Status Groups: Diagnosis, Treatment Phases, and Outcomes in the Literature, with an Illustrative Case.

Infectious diseases and therapy·2026
Same journal

Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries.

Infectious diseases and therapy·2026
Same journal

Diagnostic Performance and Cost-Effectiveness of BALF mNGS in Older Adults with Pulmonary Infections.

Infectious diseases and therapy·2026
Same journal

Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands.

Infectious diseases and therapy·2026
Same journal

Clinical and Economic Inpatient Burden of Influenza and Influenza-Like Illness in Germany 2019-2025: Analysis of Nationwide Hospital Data.

Infectious diseases and therapy·2026
Same journal

Interim Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States.

Infectious diseases and therapy·2026
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.2K

The problems with polio: toward eradication.

Gemma Lien1, David L Heymann

  • 1Public Health England, Wellington House, 133-155 Waterloo Road, London, SE1 8UG, UK, gemma.lien@phe.gov.uk.

Infectious Diseases and Therapy
|August 20, 2014
PubMed
Summary
This summary is machine-generated.

Global efforts to eradicate poliomyelitis (polio) face challenges. This review examines progress, vaccines, delays, and strategies for overcoming remaining barriers to achieve polio eradication.

More Related Videos

Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

14.2K
EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay
11:09

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay

Published on: September 11, 2016

10.5K

Related Experiment Videos

Last Updated: Apr 25, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.2K
Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

14.2K
EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay
11:09

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay

Published on: September 11, 2016

10.5K

Area of Science:

  • Global Health
  • Infectious Disease Epidemiology
  • Vaccinology

Background:

  • The global initiative to eradicate poliomyelitis (polio) has faced significant and unexpected obstacles.
  • Progress towards eradication has been slower than anticipated, necessitating a review of the current strategies.

Purpose of the Study:

  • To provide a comprehensive review of the progress in polio eradication efforts.
  • To analyze the reasons behind the delays in achieving eradication target dates.
  • To identify remaining barriers and outline strategies for overcoming them using the Polio Eradication and Endgame Strategic Plan.

Main Methods:

  • Review of published literature and reports on polio eradication.
  • Analysis of global vaccination coverage data.
  • Examination of epidemiological data related to poliovirus transmission.

Main Results:

  • Polio eradication efforts have made substantial progress but face persistent challenges.
  • Delays are attributed to factors including vaccine efficacy, funding, and geopolitical issues.
  • Several barriers, such as low vaccination rates in specific regions and virus reservoirs, remain.

Conclusions:

  • Overcoming the remaining barriers requires sustained political will, increased funding, and targeted interventions.
  • The Polio Eradication and Endgame Strategic Plan provides a framework for addressing these challenges.
  • Continued global collaboration is essential to achieve the final stages of polio eradication.